These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17566644)

  • 61. The acute effects of 3-nitropropionic acid on the behavior and spontaneous cortical electrical activity of rats.
    Lukács A; Szabó A; Vezér T; Papp A
    Acta Neurobiol Exp (Wars); 2006; 66(3):227-33. PubMed ID: 17133954
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Deregulation of Cdk5 in neuronal death and neurodegenerative diseases].
    Saito T
    Tanpakushitsu Kakusan Koso; 2009 Jun; 54(7):820-4. PubMed ID: 19514268
    [No Abstract]   [Full Text] [Related]  

  • 63. Apoptosis in the striatum of rats following intraperitoneal injection of 3-nitropropionic acid.
    Sato S; Gobbel GT; Honkaniemi J; Li Y; Kondo T; Murakami K; Sato M; Copin JC; Chan PH
    Brain Res; 1997 Jan; 745(1-2):343-7. PubMed ID: 9037431
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin.
    Ludolph AC; He F; Spencer PS; Hammerstad J; Sabri M
    Can J Neurol Sci; 1991 Nov; 18(4):492-8. PubMed ID: 1782616
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Autophagy, mitochondria and 3-nitropropionic acid joined in the same model.
    González-Polo RA; Bravo-San Pedro JM; Gómez-Sánchez R; Pizarro-Estrella E; Niso-Santano M; Fuentes JM
    Br J Pharmacol; 2013 Jan; 168(1):60-2. PubMed ID: 22946678
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Calpains as a target for therapy of neurodegenerative diseases: putative role of lithium.
    Camins A; Crespo-Biel N; Junyent F; Verdaguer E; Canudas AM; Pallàs M
    Curr Drug Metab; 2009 Jun; 10(5):433-47. PubMed ID: 19689241
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Calpain inhibitor nanocrystals prepared using Nano Spray Dryer B-90.
    Baba K; Nishida K
    Nanoscale Res Lett; 2012 Aug; 7(1):436. PubMed ID: 22863139
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An Update of Kaempferol Protection against Brain Damage Induced by Ischemia-Reperfusion and by 3-Nitropropionic Acid.
    López-Sánchez C; Lagoa R; Poejo J; García-López V; García-Martínez V; Gutierrez-Merino C
    Molecules; 2024 Feb; 29(4):. PubMed ID: 38398528
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Genetic impairment of succinate metabolism disrupts bioenergetic sensing in adrenal neuroendocrine cancer.
    Gupta P; Strange K; Telange R; Guo A; Hatch H; Sobh A; Elie J; Carter AM; Totenhagen J; Tan C; Sonawane YA; Neuzil J; Natarajan A; Ovens AJ; Oakhill JS; Wiederhold T; Pacak K; Ghayee HK; Meijer L; Reddy S; Bibb JA
    Cell Rep; 2022 Aug; 40(7):111218. PubMed ID: 35977518
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Three decades of Cdk5.
    Pao PC; Tsai LH
    J Biomed Sci; 2021 Nov; 28(1):79. PubMed ID: 34814918
    [TBL] [Abstract][Full Text] [Related]  

  • 71. When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer's and Huntington's Disease.
    D'Mello SR
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072862
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Early Reactive A1 Astrocytes Induction by the Neurotoxin 3-Nitropropionic Acid in Rat Brain.
    Lopez-Sanchez C; Garcia-Martinez V; Poejo J; Garcia-Lopez V; Salazar J; Gutierrez-Merino C
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443829
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Decreasing Levels of the cdk5 Activators, p25 and p35, Reduces Excitotoxicity in Striatal Neurons.
    Park KH; Lu G; Fan J; Raymond LA; Leavitt BR
    J Huntingtons Dis; 2012; 1(1):89-96. PubMed ID: 24353748
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Glycogen accumulation in cardiomyocytes and cardiotoxic effects after 3NPA treatment.
    Milutinović A; Zorc-Pleskovič R
    Bosn J Basic Med Sci; 2012 Feb; 12(1):15-9. PubMed ID: 22364298
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Regulation of myocyte enhancer factor-2 transcription factors by neurotoxins.
    She H; Mao Z
    Neurotoxicology; 2011 Oct; 32(5):563-6. PubMed ID: 21741404
    [TBL] [Abstract][Full Text] [Related]  

  • 76. 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future.
    Túnez I; Tasset I; Pérez-De La Cruz V; Santamaría A
    Molecules; 2010 Feb; 15(2):878-916. PubMed ID: 20335954
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dopaminergic and glutamatergic signaling crosstalk in Huntington's disease neurodegeneration: the role of p25/cyclin-dependent kinase 5.
    Paoletti P; Vila I; Rifé M; Lizcano JM; Alberch J; Ginés S
    J Neurosci; 2008 Oct; 28(40):10090-101. PubMed ID: 18829967
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration.
    Vosler PS; Brennan CS; Chen J
    Mol Neurobiol; 2008 Aug; 38(1):78-100. PubMed ID: 18686046
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Enhanced tau phosphorylation in the hippocampus of mice treated with 3,4-methylenedioxymethamphetamine ("Ecstasy").
    Busceti CL; Biagioni F; Riozzi B; Battaglia G; Storto M; Cinque C; Molinaro G; Gradini R; Caricasole A; Canudas AM; Bruno V; Nicoletti F; Fornai F
    J Neurosci; 2008 Mar; 28(12):3234-45. PubMed ID: 18354027
    [TBL] [Abstract][Full Text] [Related]  

  • 80. 3-Nitropropionic acid activates calpain/cdk5 pathway in rat striatum.
    Crespo-Biel N; Camins A; Pelegrí C; Vilaplana J; Pallàs M; Canudas AM
    Neurosci Lett; 2007 Jun; 421(1):77-81. PubMed ID: 17566644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.